2/9
08:30 am
ogen
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy
Medium
Report
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy
2/3
08:42 am
ogen
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program [Yahoo! Finance]
Medium
Report
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program [Yahoo! Finance]
2/3
08:30 am
ogen
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program
High
Report
Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program
2/2
08:47 am
ogen
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care [Yahoo! Finance]
Low
Report
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care [Yahoo! Finance]
2/2
08:30 am
ogen
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care
Low
Report
Oragenics to Participate in SCOPE Summit 2026 Focused on Advancing Clinical Research and Patient Care
1/14
08:30 am
ogen
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico
Medium
Report
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico